期刊文献+

检测外周血MUC1蛋白双抗体夹心ELISA方法的建立及初步应用 被引量:7

Establishment and preliminary application of indirect sandwich ELISA for MUC1 protein detection in peripheral blood
下载PDF
导出
摘要 目的为提高外周血MUC1蛋白检测的敏感度,建立了抗MUC1多克隆抗体的夹心ELISA试剂盒,并对其进行了初步测试。方法首先成功构建-表达并纯化了MUC1-GST和MUC1-MBP融和蛋白;通过免疫家兔和大鼠,获得抗MUC1血清,经饱和硫酸铵沉淀、Protein A/G纯化及抗GST和MBP抗体吸收的进一步纯化获得纯的家兔抗人及大鼠抗人MUC1多克隆抗体;通过凝血酶溶解MUC1-GST获得MUC1标准品。经不同的筛选确立了以家兔抗人MUC1抗体作为包被抗体、大鼠抗MUC1抗体作为检测抗体的双抗体夹心试剂盒,敏感度可达到0.2 ng/ml。结果对32例乳腺癌患者和20例健康受试者外周血血清中MUC1蛋白水平的检测结果显示,乳腺癌患者的阳性检出率达到53.1%(17例/32例),而健康对照组检出率为0。结论本研究建立的抗MUC1多克隆抗体双夹心试剂盒有望应用于临床诊断。 To establish and apply an indirect sandwich ELISA kit for MUC1 protein detection in peripheral blood.The MUC1-GST and MUC1-MBP fusion protein were expressed and purified,and then anti-MUC1 serum was obtained by immunization of rabbits and rats. In order to further purify rabbit and rat anti-human MUC1 polyclonal antibody,the serum was purified using saturated ammonium sulfate, protein A/G,and anti-GST and anti-MBP antibody absorption.The standard MUC1 peptide was prepared with MUC1-GST dissolved by thrombin.In the indirect sandwich ELISA kit,rabbit anti-human MUC1 antibodies and rat anti-MUC1 antibodies were used as coating antibodies and detecting antibodies,respectively.The sensitivity of the indirect sandwich ELISA kit was up to 0.2 ng/ml.It was detected that the levels of MUC1 protein in the peripheral blood serum of 32 cases of breast cancer patients and 20 healthy subjects,which means the positive detection rate of breast cancer patients was 53.1%(17 cases / 32 cases),while 0 in healthy control group.All the results support that the established anti-MUC1 polyclonal antibody indirect sandwich ELISA kit is sensitive and expected to be used in clinical diagnosis.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第1期49-52,55,共5页 Immunological Journal
基金 吉林省科技发展计划支撑重点项目(20080931)
关键词 MUC1 抗MUC1多克隆抗体 双抗体夹心ELISA 腺癌诊断 MUC1 Anti-MUC1 polyclonal antibody Indirect sandwich ELISA Adenocarcinoma diagnosis
  • 相关文献

参考文献11

  • 1Creaney J, Segal A, Sterre tt G, et al. Overexpression and altered glycosylation of MUC1 in malignant mesothelioma[J] Br J Cancer, 2008,98 (9): 1562-1569.
  • 2Yang E, Hu XF, Xing PX. Advances of MUC1 as a target for breast cancer immunotherapy [J]. Histol Histopathol, 2007, 22 (8): 905-922.
  • 3Alix Panabi b res C, Brouillet JP, Fabbro M, et al. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients[J]. J Immunol Methods, 2005, 299 (1/2): 177-188.
  • 4Kim HS, Park YH, Park MJ, et al. Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer [J]. Breast Cancer Res Treat, 2009, [Epub ahead of print].
  • 5Molino A, Colombatti M, Bonetti F, et al. A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow [J]. Cancer, 1991, 67(4):1033-1036.
  • 6Ross AA, Cooper BW, Lazarus HM, et al. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [J]. Blood, 1993, 82 (9): 2605-2610.
  • 7Croce MV, Isla Larrain MT, Demichelis SO, et al. Tissue and serum MUC1 mucin detection in breast cancer patients[J]. Breast Cancer Res Treat, 2003, 81 (3): 195-207.
  • 8Uen YH, Lin SR, Wu CH, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma [J]. Clin Chim Acta, 2006, 367 (1/2): 55-61.
  • 9Felton T, Harris GC, Pinder SE, et al. Identification ofcarcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1[J]. Breast, 2004, 13 (1): 35-41.
  • 10Gold DV, Modrak DE, Ying Z, et al. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis[J]. J Clin Oncol, 2006, 24 (2): 252-258.

同被引文献66

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部